Bml 259
CDK5, p25 kinase inhibitor
Product Specifications
Background
Bml 259 is a potent inhibitor of Cdk5/p25. It also inhibits Cdk2/cyclin E.
CAS Number
267654-00-2
Product Name Alternative
N- (5-Isopropylthiazol-2-yl) phenylacetamide
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cell Signaling | Cancer | Apoptosis | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors
Purity
≥98% (TLC)
Weight
0.025
Format
White solid
Solubility
Soluble in DMSO (30 mg/ml), dimethyl formamide (30 mg/ml) or 100% ethanol (0.25 mg/ml)
Molecular Formula
C14H16N2OS
Molecular Weight
260.4
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Kaźmierczak A., Czapski G.A., Adamczyk A., Gajkowska B., & Strosznajder J.B. (2011) Neurochem. Int. 58(2): 206–214.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2809-500 1x 500 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/2809R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details